ClinVar Miner

Submissions for variant NM_033056.4(PCDH15):c.5557A>C (p.Met1853Leu)

gnomAD frequency: 0.00020  dbSNP: rs145903555
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000154360 SCV000204023 likely benign not specified 2016-02-25 criteria provided, single submitter clinical testing p.Met1853Leu in exon 33 of PCDH15: This variant is not expected to have clinica l significance because it has been identified in 0.4% (61/16510) of South Asian chromosomes, including 1 homozygote, by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs145903555). Although this variant has been previously reported in compound heterozygosity with a pathogenic variant i n one Ashkenazi Jewish individual with Usher syndrome, it was also detected in 0 .32% (9/2836) of control chromosomes from various Ashkenazi and non-Ashkenazi Je wish populations. In addition, computational prediction tools and conservation a nalyses suggest that this variant may not impact the protein. In summary, due t o the frequency of this variant in the general population, it is likely benign.
Labcorp Genetics (formerly Invitae), Labcorp RCV000879612 SCV001022656 benign not provided 2024-11-19 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001104785 SCV001261672 likely benign Usher syndrome type 1 2017-06-24 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
GeneDx RCV000879612 SCV001778452 likely benign not provided 2021-03-30 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 30245029, 21569298, 18727382, 15028842, 12711741, 25262649, 20672374)
CeGaT Center for Human Genetics Tuebingen RCV000879612 SCV004701348 likely benign not provided 2024-01-01 criteria provided, single submitter clinical testing PCDH15: BP4
Clinical Genetics, Academic Medical Center RCV000154360 SCV001921743 benign not specified no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000879612 SCV001969236 likely benign not provided no assertion criteria provided clinical testing
Natera, Inc. RCV001826830 SCV002080805 likely benign Usher syndrome type 1F 2020-01-27 no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV004544404 SCV004774383 likely benign PCDH15-related disorder 2022-03-10 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.